This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by White, F A Articles by Frisque, R J Search for Related Content PubMed PubMed Citation Articles by White, F A, 3rd Articles by Frisque, R J

JC virus DNA is present in many human brain samples from patients without progressive multifocal leukoencephalopathy.

Department of Molecular and Cell Biology, Pennsylvania State University, University Park 16802.

ABSTRACT

Sections of normal and diseased brain and kidney tissues were screened for the presence of JC virus (JCV) DNA by using the polymerase chain reaction. As expected, all samples obtained from patients with progressive multifocal leukoencephalopathy (PML) tested positive when multiple JCV-specific primer and probe combinations were used. Unexpectedly, more than 50% of non-PML-affected brains were also found to harbor low levels of JCV DNA. To confirm that the positive signals seen in the tissue sections were not the result of contamination, amplified DNA was cloned and sequenced and in some cases was shown to represent strains of JCV not identified previously. Two predominant regulatory region configurations of JCV have been detected in the human host: archetype JCV, which is excreted in the urine of normal and immunocompromised individuals, and "PML-type" JCV found in diseased brains. This latter group of variants appears to derive from archetype JCV by the deletion and duplication of sequences within the promoter-enhancer region. In the present study, the archetype strain of JCV was identified only in normal kidney samples; JCV DNA found in non-PML-affected brain specimens and in kidney tissue from patients with PML resembled that of strains isolated from PML-affected brain tissue. Our findings indicate that JCV reaches the brain more frequently than previously thought and may persist at this site without causing demyelinating disease. A subsequent episode of prolonged immunodeficiency or a direct interaction with an immunocompromising agent (e.g., human immunodeficiency virus type 1) might activate the latent JCV infection and lead to the development of PML.

This article has been cited by other articles:

• Love, S (2006). Demyelinating diseases.. J. Clin. Pathol. 59: 1151-1159 [Abstract] [Full Text]  
• Laghi, L., Randolph, A. E., Malesci, A., Boland, C. R. (2004). Constraints imposed by supercoiling on in vitro amplification of polyomavirus DNA. J. Gen. Virol. 85: 3383-3388 [Abstract] [Full Text]  
• Lednicky, J. A., Halvorson, S. J., Butel, J. S. (2002). PCR Detection and DNA Sequence Analysis of the Regulatory Region of Lymphotropic Papovavirus in Peripheral Blood Mononuclear Cells of an Immunocompromised Rhesus Macaque. J. Clin. Microbiol. 40: 1056-1059 [Abstract] [Full Text]  
• Ricciardiello, L., Chang, D. K., Laghi, L., Goel, A., Chang, C. L., Boland, C. R. (2001). Mad-1 Is the Exclusive JC Virus Strain Present in the Human Colon, and Its Transcriptional Control Region Has a Deleted 98-Base-Pair Sequence in Colon Cancer Tissues. J. Virol. 75: 1996-2001 [Abstract] [Full Text]  
• Arbour, N., Day, R., Newcombe, J., Talbot, P. J. (2000). Neuroinvasion by Human Respiratory Coronaviruses. J. Virol. 74: 8913-8921 [Abstract] [Full Text]  
• Okada, Y., Sawa, H., Tanaka, S., Takada, A., Suzuki, S., Hasegawa, H., Umemura, T., Fujisawa, J.-i., Tanaka, Y., Hall, W. W., Nagashima, K. (2000). Transcriptional Activation of JC Virus by Human T-lymphotropic Virus Type I Tax Protein in Human Neuronal Cell Lines. J. Biol. Chem. 275: 17016-17023 [Abstract] [Full Text]  
• Ciappi, S, Azzi, A, De Santis, R, Leoncini, F, Sterrantino, G, Mazzotta, F, Mecocci, L (1999). Archetypal and rearranged sequences of human polyomavirus JC transcription control region in peripheral blood leukocytes and in cerebrospinal fluid. J. Gen. Virol. 80: 1017-1023 [Abstract]  
• Simon, M. A., Ilyinskii, P. O., Baskin, G. B., Knight, H. Y., Pauley, D. R., Lackner, A. A. (1999). Association of Simian Virus 40 with a Central Nervous System Lesion Distinct from Progressive Multifocal Leukoencephalopathy in Macaques with AIDS. Am. J. Pathol. 154: 437-446 [Abstract] [Full Text]  
• Ou, W., Wang, M, Fung, C., Tsai, R., Chao, P., Hseu, T., Chang, D (1999). The major capsid protein, VP1, of human JC virus expressed in Escherichia coli is able to self-assemble into a capsid-like particle and deliver exogenous DNA into human kidney cells. J. Gen. Virol. 80: 39-46 [Abstract]  
• Monaco, M. C. G., Jensen, P. N., Hou, J., Durham, L. C., Major, E. O. (1998). Detection of JC Virus DNA in Human Tonsil Tissue: Evidence for Site of Initial Viral Infection. J. Virol. 72: 9918-9923 [Abstract] [Full Text]  
• Liu, C. K., Wei, G., Atwood, W. J. (1998). Infection of Glial Cells by the Human Polyomavirus JC Is Mediated by an N-Linked Glycoprotein Containing Terminal alpha (2-6)-Linked Sialic Acids. J. Virol. 72: 4643-4649 [Abstract] [Full Text]  
• Ferrante, P, Omodeo-Zorini, E, Caldarelli-Stefano, R, Mediati, M, Fainardi, E, Granieri, E, Caputo, D (1998). Detection of JC virus DNA in cerebrospinal fluid from multiple sclerosis patients. Mult Scler 4: 49-54 [Abstract]  
• Bogdanovic, G., Priftakis, P., Hammarin, A.-L., Söderström, M., Samuelson, A., Lewensohn-Fuchs, I., Dalianis, T. (1998). Detection of JC Virus in Cerebrospinal Fluid (CSF) Samples from Patients with Progressive Multifocal Leukoencephalopathy but Not in CSF Samples from Patients with Herpes Simplex Encephalitis, Enteroviral Meningitis, or Multiple Sclerosis. J. Clin. Microbiol. 36: 1137-1138 [Abstract] [Full Text]